Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus.
Benhamou
Yves
Y
Service d'Héparo-Gastroentérologie, Hôpital Pitié-Salpêtrière, 27 Boulevard de l'Hôpital, 75013 Paris, France. ybenhamou@teaser.fr
Poynard
Thierry
T
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000627:therapeutic use*; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D011355:Prodrugs / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D000068698:Tenofovir
D000998:Antiviral Agents; D016898:Interferon-alpha; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D011355:Prodrugs; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D000068698:Tenofovir; D000225:Adenine; C106812:adefovir dipivoxil